Company
United StatesPublic company, NASDAQ: MNKDMannKind Corporation (NASDAQ: MNKD), Danbury, CT – FDA Inspections
Inspection records and compliance data for MannKind Corporation in Danbury, Connecticut. 5 FDA inspections on record, last inspected November 04, 2025. Publicly traded as NASDAQ: MNKD.
Company Profile
This profile covers MannKind Corporation based in Danbury, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 3
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected December 4, 2009. Last inspected November 4, 2025.
Most cited issue areas
- Actual vs. theoretical yields not determined1 inspection
- Extent of discrepancy, failure investigations1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 4, 2025 | NAI | Human Drugs · Drug Quality Assurance | 1292892 |
| August 6, 2021 | VAI | Human Drugs · Drug Quality Assurance | 1148015 |
| June 19, 2018 | NAI | Human Drugs, Medical Devices & Rad Health · Drug Quality Assurance | 1059556 |
| May 17, 2013 | VAI | Human Drugs · Drug Quality Assurance | 831784 |
| December 4, 2009 | VAI | Human Drugs, Medical Devices & Rad Health · Drug Quality Assurance | 631965 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
MannKind Corporation
Stock ticker
MNKD
Exchange
NASDAQ
Share price
$4.16
Market cap
$1.3B
Price as of
November 13, 2026
FEI Number
3005340341
Address
1 Casper St, Danbury, Connecticut 06810, United States
Country
United States
ID: b311f335-89a1-47a3-a7dc-24d2943cf1d4